GLIDE Information Session

Featuring ARPA-H Program Manager Dr. Kimberley Steele

August 14, 2:00 p.m. CT

 What if doctors were able to prevent and cure human disease by targeting the lymphatic system?

Kimberley Steele, M.D., Ph.D., ARPA-H Program Manager, will join the Investor Catalyst Hub and Customer Experience Hub for an information session to discuss ARPA-H’s new Groundbreaking Lymphatic Interventions and Drug Exploration (GLIDE) program, which envisions a future where doctors have a wide variety of therapeutic tools targeting abnormal lymphatic structure and function.

GLIDE aims to advance lymphatic medicine, improve our understanding of the role of lymphatic dysfunction in disease, and build effective, affordable, and accessible treatment options.

Event Details

What: GLIDE Information Session
When: Wednesday, August 14, 3:00 p.m. ET / 12:00 p.m. PT
Who: Current Customer Experience Hub and Investor Catalyst Hub members
Where: Zoom virtual meeting

You can also register now for GLIDE’s Proposers’ Day on Tuesday, September 17.